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Open access under CC BY-NThe need for hypothesis testing in MMTV-like
virus (MMTV-LV) studiesTo the Editor:
We thank Selmi and Gershwin [1] for their interest in
our work [2] and wish to make the following comments
in response to their letter.
Actually, we had acknowledged their previous obser-
vations suggesting a lack of evidence for a role of mouse
mammary tumor virus (MMTV) in primary biliary cir-
rhosis (PBC) [3]. Selmi et al. [3] did not detect
MMTV-LV in any of the six PBC liver samples whilst
we detected the virus in 3/26 PBC liver samples in our
study, indicating that their small sample size and use
of single round PCR could be responsible for the dis-
crepancies in the reported detection of MMTV-LV in
PBC between their study and ours. We used a nested
PCR based on published primers [4,5] to detect
MMTV-LV which is present at low copy number in hu-
man tissue [6]. There is also no statistically signiﬁcant
diﬀerence in the prevalence of MMTV-LV in our study
cohort compared to the cohort used in their study
(P = 1.0), indicating the virus is detectable in only a
low percentage of PBC livers, similar to other liver
conditions.
The authors mentioned that our utilization of paraf-
ﬁn-embedded and fresh liver tissues may have been a
source of contamination. We consider this unlikely.
We have demonstrated MMTV-LV in many tissues with
the utilisation of best practice molecular techniques [6–
9], including the change of microtome blades between
sample blocks to prevent carry-over contamination,
use of separate rooms for the isolation of sample
DNA and preparation of PCR and inclusion of negative
water and extraction controls. Furthermore, we have
previously conﬁrmed the presence of MMTV-LV using
in situ PCR [8].
Sequencing was performed on a subset of positive
samples (32/53; 60%) in our study as a means of conﬁr-
mation of the presence of the virus. As mentioned in our
paper, due to limited sample availability we were only
able to sequence the MMTV amplicons from 32 sam-
ples. However, we have sequenced all amplicons in other
settings [6,7,9] and these ﬁndings have conﬁrmed the
presence of the virus.
The number of healthy controls in our study
ðn ¼ 20Þ was comparable to the number of PBC sam-
ples ðn ¼ 26Þ tested. In other published studies exam-
ining other (particularly breast) tissues, we have
included up to 120 normal tissues as controls [7–9].
These have yielded consistent results over a period
of years. Most importantly, there are enough controlsC-ND license.in the published study to make statistically signiﬁcant
observations regarding diﬀerences in detection of the
virus.
The data from our study argue against a role for
MMTV-LV in the pathogenesis of either PBC or a
range of other chronic liver disorders or complicating
hepatocellular carcinoma. Our ﬁndings suggest that
MMTV-LV is likely to be more complex than purely
associative with pathological conditions. A possible
linkage with endocrine factors, as we allude to in
our study, is a hypothesis we are currently investigat-
ing, particularly given the signiﬁcant association be-
tween hormonal factors and upregulation of the
MMTV promoter in mice.
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